“Alzheimer’s disease therapeutics & biofluid tests: Current practice and future prospects”
28th October 2021
The webinar will last 90 minutes
Register at: https://www.workcast.com/register?cpak=5390610616631173
Time Zones: 9:30 AM Pacific Time, 6:30 PM European Time, 13:30 PM Argentina Time
Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone.
To calculate this, you can use the time zone converter tool here
This session will provide an overview of the rapidly evolving landscape of: (i) the use, reporting and interpretation of cerebrospinal fluid (CSF) Alzheimer’s disease biomarkers in clinical care, (ii) the development of peripheral (i.e.,blood-based) biomarkers and assays for Alzheimer’s disease, and (iii) the state of disease-modifying therapeutics for Alzheimer’s disease, including current and future uses of biomarkers related to therapeutics.
The Webinar will consist of three talks (20 minutes each) and will be followed by the panel discussion - Registrants will be able to ask questions to the presenters.
Chair: Dr. Robert Rissman (USA)
Talk 1: A primer on Alzheimer’s neuropathology and current treatments
Speaker: Dr. Haakon B. Nygaard (Canada)
Talk 2: Clinical implementation of CSF biomarkers for Alzheimer’s disease
Speaker: Dr. Mari DeMarco (Canada)
Talk 3: Blood-based biomarkers of Alzheimer’s disease
Speaker: Dr. Melissa Budelier (USA)
